Effect of autophagy on multiple myeloma cell viability
Tóm tắt
Because accumulation of potentially toxic malfolded protein may be extensive in immunoglobulin-producing multiple myeloma (MM) cells, we investigated the phenomenon of autophagy in myeloma, a physiologic process that can protect against malfolded protein under some circumstances. Autophagy in MM cell lines that express and secrete immunoglobulin and primary specimens was significantly increased by treatment with the endoplasmic reticulum stress–inducing agent thapsigargin, the mammalian target of rapamycin inhibitor rapamycin, and the proteasome inhibitor bortezomib. Inhibition of basal autophagy in these cell lines and primary cells by use of the inhibitors 3-methyladenine and chloroquine resulted in a cytotoxic effect that was associated with enhanced apoptosis. Use of small interfering RNA to knock down expression of beclin-1, a key protein required for autophagy, also inhibited viable recovery of MM cells. Because the data suggested that autophagy protected MM cell viability, we predicted that autophagy inhibitors would synergize with bortezomib for enhanced antimyeloma effects. However, the combination of these drugs resulted in an antagonistic response. In contrast, the autophagy inhibitor 3-methyladenine did synergize with thapsigargin for an enhanced cytotoxic response. These data suggest that autophagy inhibitors have therapeutic potential in myeloma but caution against combining such drugs with bortezomib. [Mol Cancer Ther 2009;8(7):1974–84]
Từ khóa
Tài liệu tham khảo
Hideshima, 2005, Intracellular protein degradation and its therapeutic implications, Clin Cancer Res, 11, 8530, 10.1158/1078-0432.CCR-05-2305
Mitsiades, 2006, Antimyeloma activity of heat shock protein-90 inhibition, Blood, 107, 1092, 10.1182/blood-2005-03-1158
Obeng, 2006, Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells, Blood, 107, 4907, 10.1182/blood-2005-08-3531
Lee, 2003, Proteasome inhibitors disrupt the unfolded protein response in myeloma cells, Proc Natl Acad Sci U S A, 100, 9946, 10.1073/pnas.1334037100
Landowski, 2005, Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines, Cancer Res, 65, 3828, 10.1158/0008-5472.CAN-04-3684
Catley, 2006, Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells, Blood, 108, 3441, 10.1182/blood-2006-04-016055
Maiso, 2006, The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance, Cancer Res, 66, 5781, 10.1158/0008-5472.CAN-05-4186
Hideshima, 2001, The proteasome inhibitor PS-341 inhibits growth, induces apoptosis and overcomes drug resistance in human multiple myeloma cells, Cancer Res, 61, 3071
Richardson, 2003, A phase 2 study of bortezomib in relapsed, refractory multiple myeloma, N Engl J Med, 348, 2609, 10.1056/NEJMoa030288
Meister, 2007, Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition, Cancer Res, 67, 1783, 10.1158/0008-5472.CAN-06-2258
Hippert, 2006, Autophagy in cancer: good, bad or both, Cancer Res, 66, 9349, 10.1158/0008-5472.CAN-06-1597
Levine, 2004, Development by self-digestion: molecular mechanisms and biological functions of autophagy, Dev Cell, 6, 463, 10.1016/S1534-5807(04)00099-1
Yorimitsu, 2005, Autophagy: molecular machinery for self-eating, Cell Death Differ, 12, 1542, 10.1038/sj.cdd.4401765
Klionsky, 2005, The molecular machinery of autophagy: unanswered questions, J Cell Sci, 118, 7, 10.1242/jcs.01620
Cuervo, 2004, Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy, Science, 305, 1292, 10.1126/science.1101738
Iwata, 2005, Increased susceptibility to cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation, Proc Natl Acad Sci U S A, 102, 13135, 10.1073/pnas.0505801102
Ravikumar, 2004, Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease, Nat Genet, 36, 585, 10.1038/ng1362
Travers, 2000, Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation, Cell, 101, 249, 10.1016/S0092-8674(00)80835-1
Ogata, 2006, Autophagy is activated for cell survival after endoplasmic reticulum stress, Mol Cell Biol, 26, 9220, 10.1128/MCB.01453-06
Kouroku, 2007, ER stress (PERK/eIF2α phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation, Cell Death Differ, 14, 230, 10.1038/sj.cdd.4401984
Shi, 2002, Signal pathways involved in activation of p70 and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to IL-6, J Biol Chem, 277, 15712, 10.1074/jbc.M200043200
Hu, 2003, Downstream effectors of oncogenic ras in multiple myeloma cells, Blood, 101, 3126, 10.1182/blood-2002-08-2640
Shi, 2005, Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade, Mol Cancer Ther, 4, 1533, 10.1158/1535-7163.MCT-05-0068
Yan, 2006, Mechanism by which mTOR inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis, Cancer Res, 66, 2305, 10.1158/0008-5472.CAN-05-2447
An, 2007, Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib, Mol Cancer Ther, 6, 61, 10.1158/1535-7163.MCT-06-0255
Thastrup, 1990, Thapsigargin, a tumor promoter, discharges intracellular Ca stores by specific inhibition of the ER Ca2(+)-ATPase, Proc Natl Acad Sci U S A, 87, 2466, 10.1073/pnas.87.7.2466
Blommaart, 1995, Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes, J Biol Chem, 270, 2320, 10.1074/jbc.270.5.2320
Frost, 2004, In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model, Blood, 104, 4181, 10.1182/blood-2004-03-1153
Paglin, 2005, Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy and survival in irradiated MCF-7 cells, Cancer Res, 65, 11061, 10.1158/0008-5472.CAN-05-1083
Kabeya, 2000, LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing, EMBO J, 19, 5720, 10.1093/emboj/19.21.5720
Klionsky, 2008, Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes, Autophagy, 4, 151, 10.4161/auto.5338
Seglen, 1982, 3-Methyladenine; specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes, Proc Natl Acad Sci U S A, 79, 1889, 10.1073/pnas.79.6.1889
Boya, 2005, Inhibition of macroautophagy triggers apoptosis, Mol Cell Biol, 25, 1025, 10.1128/MCB.25.3.1025-1040.2005
Yamamoto, 1998, Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line H-4-II-E, Cell Struct Funct, 23, 33, 10.1247/csf.23.33
Liang, 1999, Induction of autophagy and inhibition of tumorigenesis by beclin 1, Nature, 402, 672, 10.1038/45257
Kihara, 2001, Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network, EMBO Rep, 2, 330, 10.1093/embo-reports/kve061
Schmeizle, 2000, TOR, a central controller of cell growth, Cell, 103, 253, 10.1016/S0092-8674(00)00117-3
Yorimitsu, 2006, Endoplasmic reticulum stress triggers autophagy, J Biol Chem, 281, 30299, 10.1074/jbc.M607007200
Hideshima, 2003, Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341, Blood, 101, 1530, 10.1182/blood-2002-08-2543
Ding, 2007, Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability, Am J Pathol, 171, 513, 10.2353/ajpath.2007.070188
Codogno, 2005, Autophagy and signaling: their role in cell survival and cell death, Cell Death Differ, 12, 1509, 10.1038/sj.cdd.4401751
Bernales, 2006, Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response, PLOS Biol, 4, 2311, 10.1371/journal.pbio.0040423
Landowski, 2008, Inhibition of autophagy promotes bortezomib-mediated cell death in myeloma cells, Blood, 112, 1259a, 10.1182/blood.V112.11.3677.3677
Shen, 2008, The rationale for combined proteasome and autophagy inhibition in multiple myeloma established using novel translational platforms, Blood, 112, 951a, 10.1182/blood.V112.11.2755.2755
Yang, 2006, Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells, Cancer Lett, 243, 217, 10.1016/j.canlet.2005.11.033